scholarly article | Q13442814 |
P356 | DOI | 10.3109/01676830903104611 |
P698 | PubMed publication ID | 19839884 |
P50 | author | Paolo Beck-Peccoz | Q46152118 |
Irene Campi | Q59548561 | ||
Mario Salvi | Q60311689 | ||
P2093 | author name string | Guia Vannucchi | |
P433 | issue | 4 | |
P921 | main subject | rituximab | Q412323 |
eye disease | Q3041498 | ||
P304 | page(s) | 251-255 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Orbit | Q7100035 |
P1476 | title | Rituximab in the treatment of thyroid eye disease: science fiction? | |
P478 | volume | 28 |
Q38617832 | Advances in the management of thyroid eye diseases: An overview |
Q36886212 | Impact of methimazole treatment on magnesium concentration and lymphocytes activation in adolescents with Graves' disease. |
Q51321732 | Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports. |
Q44766839 | Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy. |
Q35725329 | The evolving role of selenium in the treatment of graves' disease and ophthalmopathy |
Q36439938 | The pathophysiology of thyroid eye disease: implications for immunotherapy. |
Q38275638 | Treatment modalities of thyroid related orbitopathy |
Search more.